PUBLICATIONS · 19114685
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Feb 10
- First author
- Hecht JR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2009 Feb 10;27(5):655-8. doi: 10.1200/JCO.2008.21.2522.
- note
- Source null
- related pmid
- 19114682
- relationship
- Comment in
- citation
- Immunotherapy. 2009 May;1(3):339-40.
- note
- Source null
- related pmid
- 20653090
- relationship
- Comment in
Authors and identifiers
- name
- Hecht JR
- type
- Author
- name
- Mitchell E
- type
- Author
- name
- Chidiac T
- type
- Author
- name
- Scroggin C
- type
- Author
- name
- Hagenstad C
- type
- Author
- name
- Spigel D
- type
- Author
- name
- Marshall J
- type
- Author
- name
- Cohn A
- type
- Author
- name
- McCollum D
- type
- Author
- name
- Stella P
- type
- Author
- name
- Deeter R
- type
- Author
- name
- Shahin S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hecht JR
- type
- Author
- name
- Mitchell E
- type
- Author
- name
- Chidiac T
- type
- Author
- name
- Scroggin C
- type
- Author
- name
- Hagenstad C
- type
- Author
- name
- Spigel D
- type
- Author
- name
- Marshall J
- type
- Author
- name
- Cohn A
- type
- Author
- name
- McCollum D
- type
- Author
- name
- Stella P
- type
- Author
- name
- Deeter R
- type
- Author
- name
- Shahin S
- type
- Author
- bibliography ids
- nci-bib-488c51186f2c740e348170d2
- book metadata
- content sha256
- 3ff088f68683e2b53ad462c2cb418daa3dc96ceb4452a94b20a67ce99aa2f289
- document type
- citation
- dois
- 10.1200/JCO.2008.19.8135
- electronic publication date
- display
- 2008 Dec 29
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19114685
- immutable id
- pubmed:19114685@3ff088f68683e2b53ad462c2cb418daa3dc96ceb4452a94b20a67ce99aa2f289
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 5
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 672-80
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2009 Feb 10;27(5):655-8. doi: 10.1200/JCO.2008.21.2522.
- note
- Source null
- related pmid
- 19114682
- relationship
- Comment in
- citation
- Immunotherapy. 2009 May;1(3):339-40.
- note
- Source null
- related pmid
- 20653090
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 19114685
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- 2feab6e0b03ac191a7e9a0707aa5e413d0580bd3d3b2c13094ee941e00cf4180
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Feb 10
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle